Feasibility and effects of high-dose hypofractionated radiation therapy and simultaneous multi-kinase inhibition with sunitinib in progressive metastatic renal cell cancer.
Staehler, Michael
Feasibility and effects of high-dose hypofractionated radiation therapy and simultaneous multi-kinase inhibition with sunitinib in progressive metastatic renal cell cancer. [electronic resource] - Urologic oncology - 290-3 p. digital
Publication Type: Journal Article
1873-2496
10.1016/j.urolonc.2010.02.006 doi
Adult
Aged
Aged, 80 and over
Carcinoma, Renal Cell--drug therapy
Disease Progression
Dose Fractionation, Radiation
Female
Humans
Indoles--therapeutic use
Kidney Neoplasms--drug therapy
Male
Middle Aged
Neoplasm Metastasis
Pyrroles--therapeutic use
Radiotherapy--methods
Remission Induction
Sunitinib
Time Factors
Treatment Outcome
Feasibility and effects of high-dose hypofractionated radiation therapy and simultaneous multi-kinase inhibition with sunitinib in progressive metastatic renal cell cancer. [electronic resource] - Urologic oncology - 290-3 p. digital
Publication Type: Journal Article
1873-2496
10.1016/j.urolonc.2010.02.006 doi
Adult
Aged
Aged, 80 and over
Carcinoma, Renal Cell--drug therapy
Disease Progression
Dose Fractionation, Radiation
Female
Humans
Indoles--therapeutic use
Kidney Neoplasms--drug therapy
Male
Middle Aged
Neoplasm Metastasis
Pyrroles--therapeutic use
Radiotherapy--methods
Remission Induction
Sunitinib
Time Factors
Treatment Outcome